215 related articles for article (PubMed ID: 12020489)
1. Neurohormonal activation rapidly decreases after intravenous therapy with diuretics and vasodilators for class IV heart failure.
Johnson W; Omland T; Hall C; Lucas C; Myking OL; Collins C; Pfeffer M; Rouleau JL; Stevenson LW
J Am Coll Cardiol; 2002 May; 39(10):1623-9. PubMed ID: 12020489
[TBL] [Abstract][Full Text] [Related]
2. Sustained hemodynamic efficacy of therapy tailored to reduce filling pressures in survivors with advanced heart failure.
Steimle AE; Stevenson LW; Chelimsky-Fallick C; Fonarow GC; Hamilton MA; Moriguchi JD; Kartashov A; Tillisch JH
Circulation; 1997 Aug; 96(4):1165-72. PubMed ID: 9286945
[TBL] [Abstract][Full Text] [Related]
3. [Therapy of advanced heart failure adapted to hemodynamic objectives acquired by invasive hemodynamic monitoring].
Almeida Júnior GL; Esporcatte R; Rangel FO; Rocha RM; Gouvêa e Silva Gde M; Tura BR; Jorge JK; Drumond LE; Albanesi Filho FM
Arq Bras Cardiol; 2005 Oct; 85(4):247-53. PubMed ID: 16283030
[TBL] [Abstract][Full Text] [Related]
4. Changes in plasma N-terminal proBNP levels and ventricular filling pressures during intensive unloading therapy in elderly with decompensated congestive heart failure and preserved left ventricular systolic function.
Cioffi G; Tarantini L; Stefenelli C; Azzetti G; Marco R; Carlucci S; Furlanello F
J Card Fail; 2006 Oct; 12(8):608-15. PubMed ID: 17045179
[TBL] [Abstract][Full Text] [Related]
5. Long-term vasodilator treatment with flosequinan does not lead to hemodynamic tolerance or neurohormonal activation in severe heart failure.
Bartels GL; Remme WJ; Look MP; Kruijssen DA
J Card Fail; 1995 Mar; 1(2):117-25. PubMed ID: 9420641
[TBL] [Abstract][Full Text] [Related]
6. [Hemodynamic and humoral effects of parenteral therapy with intravenously administered ACE inhibitor quinaprilat in patients with advanced heart failure].
Mitrovic V; Mudra H; Bonzel T; Schmidt W; Schlepper M
Z Kardiol; 1996 Nov; 85(11):828-38. PubMed ID: 9064945
[TBL] [Abstract][Full Text] [Related]
7. Neurohormonal activation and congestive heart failure: today's experience with ACE inhibitors and rationale for their use.
Sigurdsson A; Swedberg K
Eur Heart J; 1995 Dec; 16 Suppl N():65-72. PubMed ID: 8682064
[TBL] [Abstract][Full Text] [Related]
8. Influence of age on neurohormonal activation and prognosis in patients with chronic heart failure.
van Veldhuisen DJ; Boomsma F; de Kam PJ; Man in't Veld AJ; Crijns HJ; Hampton JR; Lie KI
Eur Heart J; 1998 May; 19(5):753-60. PubMed ID: 9717009
[TBL] [Abstract][Full Text] [Related]
9. Positive inotropic and vasodilator actions of milrinone in patients with severe congestive heart failure. Dose-response relationships and comparison to nitroprusside.
Jaski BE; Fifer MA; Wright RF; Braunwald E; Colucci WS
J Clin Invest; 1985 Feb; 75(2):643-9. PubMed ID: 3973022
[TBL] [Abstract][Full Text] [Related]
10. Refractory acute decompensated heart failure: an observational study on a noninvasive hemodynamic monitoring system aimed at improving the therapeutic approach.
Frea S; Franco E; Najd K; Panella S; Pinneri F
J Cardiovasc Med (Hagerstown); 2010 Sep; 11(9):655-61. PubMed ID: 20308915
[TBL] [Abstract][Full Text] [Related]
11. Hemodynamic effects of inhaled nitric oxide in heart failure.
Semigran MJ; Cockrill BA; Kacmarek R; Thompson BT; Zapol WM; Dec GW; Fifer MA
J Am Coll Cardiol; 1994 Oct; 24(4):982-8. PubMed ID: 7930234
[TBL] [Abstract][Full Text] [Related]
12. The dual endothelin receptor antagonist tezosentan acutely improves hemodynamic parameters in patients with advanced heart failure.
Schalcher C; Cotter G; Reisin L; Bertel O; Kobrin I; Guyene TT; Kiowski W
Am Heart J; 2001 Aug; 142(2):340-9. PubMed ID: 11479476
[TBL] [Abstract][Full Text] [Related]
13. Sustained hemodynamic response to flosequinan in patients with heart failure receiving angiotensin-converting enzyme inhibitors.
Gottlieb SS; Kukin ML; Penn J; Fisher ML; Cines M; Medina N; Yushak M; Taylor M; Packer M
J Am Coll Cardiol; 1993 Oct; 22(4):963-7. PubMed ID: 8409070
[TBL] [Abstract][Full Text] [Related]
14. Hemodynamic and neurohumoral effects of long-term prostaglandin E1 infusions in outpatients with severe congestive heart failure.
Hülsmann M; Stanek B; Frey B; Berger R; Rödler S; Siegel A; Hartter E; Schuller M; Ogris E; Pacher R
J Heart Lung Transplant; 1997 May; 16(5):556-62. PubMed ID: 9171275
[TBL] [Abstract][Full Text] [Related]
15. Sodium nitroprusside for advanced low-output heart failure.
Mullens W; Abrahams Z; Francis GS; Skouri HN; Starling RC; Young JB; Taylor DO; Tang WH
J Am Coll Cardiol; 2008 Jul; 52(3):200-7. PubMed ID: 18617068
[TBL] [Abstract][Full Text] [Related]
16. Neurohormonal effects of furosemide withdrawal in elderly heart failure patients with normal systolic function.
van Kraaij DJ; Jansen RW; Sweep FC; Hoefnagels WH
Eur J Heart Fail; 2003 Jan; 5(1):47-53. PubMed ID: 12559215
[TBL] [Abstract][Full Text] [Related]
17. Interventions Linked to Decreased Heart Failure Hospitalizations During Ambulatory Pulmonary Artery Pressure Monitoring.
Costanzo MR; Stevenson LW; Adamson PB; Desai AS; Heywood JT; Bourge RC; Bauman J; Abraham WT
JACC Heart Fail; 2016 May; 4(5):333-44. PubMed ID: 26874388
[TBL] [Abstract][Full Text] [Related]
18. Sustained reduction in valvular regurgitation and atrial volumes with tailored vasodilator therapy in advanced congestive heart failure secondary to dilated (ischemic or idiopathic) cardiomyopathy.
Hamilton MA; Stevenson LW; Child JS; Moriguchi JD; Walden J; Woo M
Am J Cardiol; 1991 Feb; 67(4):259-63. PubMed ID: 1990789
[TBL] [Abstract][Full Text] [Related]
19. Neurohormonal activation in patients with acute myocardial infarction or chronic congestive heart failure. With special reference to treatment with angiotensin converting enzyme inhibitors.
Sigurdsson A
Blood Press Suppl; 1995; 1():1-45. PubMed ID: 7599749
[TBL] [Abstract][Full Text] [Related]
20. Neurohormonal activation, the renal dopaminergic system and sodium handling in patients with severe heart failure under vasodilator therapy.
Ferreira A; Bettencourt P; Dias P; Pestana M; Serrão P; Soares-da-Silva P; Cerqueira-Gomes M
Clin Sci (Lond); 2001 May; 100(5):557-66. PubMed ID: 11294697
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
